| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 219 | 2021 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 116 | 2021 |
| Epidemiology of antiphospholipid syndrome in the general population JY Dabit, MO Valenzuela-Almada, S Vallejo-Ramos, A Duarte-García Current rheumatology reports 23 (12), 85, 2021 | 96 | 2021 |
| Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance MF Ugarte-Gil, GS Alarcón, Z Izadi, A Duarte-García, ... Annals of the rheumatic diseases 81 (7), 970-978, 2022 | 75 | 2022 |
| Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades A Duarte-García, M Hocaoglu, M Valenzuela-Almada, SA Osei-Onomah, ... Annals of the rheumatic diseases 81 (9), 1260-1266, 2022 | 34 | 2022 |
| Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study G Figueroa-Parra, EL Gilbert, MO Valenzuela-Almada, S Vallejo, ... The Lancet Rheumatology 4 (11), e765-e774, 2022 | 32 | 2022 |
| COVID-19 Global Rheumatology Alliance. Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Ann Rheum Dis 80 (9), 1137-1146, 2021 | 26 | 2021 |
| Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population‐Based Study Over Four Decades Using the Lupus Midwest Network M Hocaoǧlu, MO Valenzuela‐Almada, JY Dabit, SA Osei‐Onomah, ... Arthritis & Rheumatology 75 (4), 567-573, 2023 | 18 | 2023 |
| Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study Z Izadi, MA Gianfrancesco, G Schmajuk, L Jacobsohn, P Katz, S Rush, ... The Lancet Rheumatology 4 (9), e603-e613, 2022 | 13 | 2022 |
| Epidemiology of Childhood‐Onset Systemic Lupus Erythematosus: A Population‐Based Study MO Valenzuela‐Almada, M Hocaoglu, JY Dabit, SA Osei‐Onomah, ... Arthritis care & research 74 (5), 728-732, 2022 | 13 | 2022 |
| Psoriasis Patient Registry for Outcomes, Therapy and Epidemiology of COVID-19 Infection (PsoProtect); the Secure Epidemiology of Coronavirus Under Research Exclusion for … Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA Netw Open 4 (10), e2129639, 2021 | 13 | 2021 |
| The protective effect of rheumatic disease agents in COVID-19 MO Valenzuela-Almada, MS Putman, A Duarte-Garcia Best Practice & Research Clinical Rheumatology 35 (1), 101659, 2021 | 12 | 2021 |
| COVID-19 in pregnant women with rheumatic disease: data from the COVID-19 global rheumatology alliance BL Bermas, M Gianfrancesco, HL Tanner, AM Seet, MC Aguiar, ... The Journal of rheumatology 49 (1), 110-114, 2022 | 11 | 2022 |
| Association between race/ethnicity and COVID‐19 outcomes in systemic lupus erythematosus patients from the United States: data from the COVID‐19 Global Rheumatology Alliance MF Ugarte‐Gil, GS Alarcón, AM Seet, Z Izadi, AD Montgomery, ... Arthritis Care & Research 75 (1), 53-60, 2023 | 10 | 2023 |
| Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry Z Izadi, MA Gianfrancesco, A Aguirre, A Strangfeld, EF Mateus, KL Hyrich, ... ACR open rheumatology 4 (10), 872-882, 2022 | 8 | 2022 |
| Long-term opioid therapy among patients with systemic lupus erythematosus in the community: a Lupus Midwest Network (LUMEN) study G Figueroa-Parra, MM Jeffery, JY Dabit, B Chevet, ... The Journal of rheumatology 50 (4), 504-511, 2023 | 5 | 2023 |
| Revisión comparativa de Artículo de revisión dolor central post-ictus y otras causas de origen encefálico: fisiopatología y tratamiento A Quintero-Villegas, MO Valenzuela-Almada, HS Álvarez-Manzo, ... Archivos de Neurociencias 23 (2), 6-24, 2018 | 3 | 2018 |
| Epidemiology of cutaneous lupus erythematosus among adults over four decades (1976-2018): a Lupus Midwest Network (LUMEN) study M Hocaoğlu, MDP Davis, SA Osei-Onomah, MO Valenzuela-Almada, ... Mayo Clinic Proceedings 97 (12), 2282-2290, 2022 | 2 | 2022 |
| OP0286 CHARACTERISTICS ASSOCIATED WITH SEVERE COVID-19 OUTCOMES IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS FROM THE COVID-19 GLOBAL RHEUMATOLOGY ALLIANCE (COVID-19 GRA) MF Ugarte-Gil, GS Alarcon, A Seet, Z Izadi, CR Sokolova, AE Clarke, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 173-175, 2021 | 2 | 2021 |
| Health care utilization in systemic lupus erythematosus in the community: the Lupus Midwest Network B Chevet, G Figueroa-Parra, MO Valenzuela-Almada, M Hocaoglu, ... JCR: Journal of Clinical Rheumatology 29 (1), 29-35, 2023 | 1 | 2023 |
